Allergy Therapeutics - PDMR Dealings & Shareholding Update
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
PDMR Dealings & Shareholding Update
Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapies, announces that the Company has been notified by ZQ Group of the following.
A re-organisation took place within ZQ Group which involved the transfer of the majority of the Company's shares previously held by SkyGem Acquisition Limited to SkyGem International Holdings Limited, both entities being within ZQ Group (the "Transfer"). The Transfer was undertaken to optimise ZQ's internal holding structure of AGY shares. The Transfer did not result in any change to the ultimate beneficial ownership of Allergy Therapeutics plc.
Separately, SkyGem International Holdings Limited placed an aggregate of 209,600,000 shares to four investors at an average price of
Following these transactions, ZQ Capital and related entities hold the following shares in Allergy Therapeutics plc:
|
Holding entity |
Number of shares |
|
SkyGem International Holdings Ltd |
3,828,575,524 |
|
SkyGem Acquisition Ltd |
2,150,665 |
|
ZQ Capital Ltd |
315,343 |
|
Shen Zheqing |
90,000 |
|
Total |
3,831,131,532 |
The aggregate holdings above represent 60.5% of the Company's issued share capital.
As a result of these transactions,
For further information, please contact:
Allergy Therapeutics
+44 (0)1903 845 820
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
+44 (0)20 7220 0500
ICR Healthcare
+44 (0)20 3709 5700
allergytherapeutics@icrhealthcare.com
Notes for editors:
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company, headquartered in the
Notification and public disclosure of transactions by Director/persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
a) |
Name |
ZQ Capital Management Limited |
|
|
2 |
Reason for the notification |
|
|
|
a) |
Position/status |
Persons closely associated Mr. |
|
|
b) |
Initial notification/Amendment |
Initial notification. |
|
|
3 |
Details of the issuer, |
||
|
a) |
Name |
Allergy Therapeutics Plc |
|
|
b) |
LEI |
213800PQ7AHK7KGVOE23 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument, type of instrument
|
Ordinary shares |
|
|
b) |
Nature of the transaction |
(1) Transfers between SkyGem Acquisition Ltd to SkyGem International Holdings Ltd (2) Transfers between SkyGem Acquisition Ltd to SkyGem UK Holding Ltd (3) Transfers between SkyGem UK Holding Ltd to SkyGem International Holdings Ltd (4) Sale of Ordinary Shares
|
|
|
c) |
Price(s) and volume(s) |
Price(s) (1) (1) (2) (3) (4) (4) (4) (4)
|
Volume(s) (1) 150,925,926 (1) 1,993,473,455 (2) 1,893,776,143 (3) 1,893,776,143 (4) 1,840,000 (4) 189,334,000 (4) 3,684,000 (4) 14,742,000
|
|
|
|
||
|
|
|||
|
d) |
Aggregated information · - Aggregated volume · - Price |
(1) 2,144,399,381 Ordinary Shares (2) 1,893,776,143 Ordinary Shares (3) 1,893,776,143 Ordinary Shares (4) 209,600,000 Ordinary Shares
(1) (2) (3) (4) |
|
|
e) |
Date of the transaction |
(1) (2) (3) (4) 27/02/2026, 27/02/2026, 02/03/2026,
|
|
|
f) |
Place of the transaction |
Outside a trading venue. |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE